# Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes

> **NCT01630369** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 552 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** insulin human (HR1799)

## Key facts

- **NCT ID:** NCT01630369
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 552 (ACTUAL)
- **Last updated:** 2014-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01630369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01630369, "Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01630369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*